Results 61 to 70 of about 2,121,252 (276)

Abstracts of the 2024 Annual Meeting of the Swiss Neurological Society (SNS): Quo Vadis Neuroinflammation? From Pathophysiologic Advances to Novel Treatment Strategies

open access: yes
On behalf of the SNS, we are pleased to present the Abstracts of the Annual Meeting which is held at the Congress Center in Basel, Switzerland, from 6–7 June 2024.
Swiss Neurological Society (SNS)   +10 more
core   +1 more source

Kongsberg Vision Meeting 2013: Abstracts [PDF]

open access: yes, 1970
Kongsberg Vision Meeting was arranged at Buskerud University College in Kongsberg for the sixth time on December 10, 2013. Rigmor C. Baraas and Gaute T. Einevoll organized the meeting. Keynote speakers were Michael Crossland from Anglia Ruskin University
Gaute T. Einevoll   +3 more
core   +2 more sources

Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty‐Related Limitation in Maintenance Hemodialysis Patients: A Cross‐Sectional Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono   +7 more
wiley   +1 more source

A room temperature indirect formic acid fuel cell [PDF]

open access: yes, 2010
published_or_final_versionThe 218th Meeting of the Electrochemical Society (ECS Meeting 2010), Las Vegas, NV., 10-15 October 2010.
Ting, SW   +4 more
core  

Abstracts autori

open access: yes, 2017
s del Simposio, in ordine alfabetico, redatti dai rispettivi ...
Autori, Abstracts, Abstracts Autori
core   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

ABSTRACTS FROM THE NORTH AMERICAN SOCIETY OF LYMPHOLOGY FOURTH BIENNIAL MEETING (OCTOBER 17-18, 1986)

open access: yes, 2017
S FROM THE NORTH AMERICAN SOCIETY OF LYMPHOLOGY FOURTH BIENNIAL MEETING (OCTOBER 17-18 ...
Meeting, Biennial
core  

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy